Product Feasibility of a New Silicone Hydrogel Contact Lens
NCT ID: NCT01309100
Last Updated: 2014-04-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
144 participants
INTERVENTIONAL
2010-11-30
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of a New Silicone Hydrogel Lens
NCT01131130
Evaluation of the Feasibility a New Silicone Hydrogel Contact Lens
NCT01309906
A Study to Evaluate a New Silicone Hydrogel Contact Lens
NCT01309893
Evaluation of a New Silicone Hydrogel Contact Lens
NCT01309880
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
NCT01412983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Investigational Lens
Bausch \& Lomb investigational silicone hydrogel lens.
Investigational Lens
Bausch \& Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.
Acuvue Oasys Lens
Johnson \& Johnson Acuvue Oasys contact lens.
Acuvue Oasys Lens
Johnson \& Johnson Acuvue Oasys contact lens on a daily wear basis for 1 week.
Air Optix Aqua Lens
Ciba Vision Air Optix Aqua contact lens.
Air Optix Aqua Lens
Ciba Vision Air Optix Aqua contact lens on a daily wear basis for 1 week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Investigational Lens
Bausch \& Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.
Acuvue Oasys Lens
Johnson \& Johnson Acuvue Oasys contact lens on a daily wear basis for 1 week.
Air Optix Aqua Lens
Ciba Vision Air Optix Aqua contact lens on a daily wear basis for 1 week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
* Subjects must be myopic and require lens correction
Exclusion Criteria
* Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
* Subjects with an active ocular disease or are using any ocular medication.
* Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tara Vaz, OD
Role: PRINCIPAL_INVESTIGATOR
Bausch & Lomb Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bausch & Lomb Incorporated
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
672E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.